Skip to main content

2seventy bio, Inc.

TSVTDelisted May 13, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001860782

2seventy bio, Inc. was delisted on May 13, 2025; its insiders filed their last Form 4 on May 15, 2025; 140 institutions reported holding it in 13F filings for Q1 2025, worth $234.5M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding 2seventy bio, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of TSVT: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1152115+2
Shares47.6M3.85M45.0M+1.25M (+2.9%)
Value$183.4M$14.8M$212.5M+$44.0M (+26.1%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held 2seventy bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to TSVT in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.3,870,096$18.3M0.00%
Western Standard LLC285,931$1.35M1.27%
PDT Partners, LLC51,713$244.1K0.02%
AJOVista, LLC20,255$95.6K0.41%
Raymond James Financial Services Advisors, Inc.17,421$82.2K0.00%
SG Americas Securities, LLC16,890$80.0K0.00%
Intech Investment Management LLC14,658$69.2K0.00%
Gsa Capital Partners LLP13,479$64.0K0.00%
Readystate Asset Management LP11,161$52.7K0.00%
Huntington National Bank233$1.10K0.00%
Sterling Capital Management LLC154$7270.00%
C M Bidwell & Associates Ltd86$4060.00%
Truvestments Capital LLC41$1940.00%
Capital Performance Advisors LLP24$1130.00%

Sold out (12)

Institutions that held 2seventy bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (2)

Institutions that held 2seventy bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TSVT in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.3,661,023$14.1M
Susquehanna Fundamental Investments, LLC192,319$740.4K